Latest News

Young Epilepsy welcomes NICE’s approval of CBD as treatment for children with epilepsy

Responding to the publication of the NICE guidelines on cannabis-based medicinal products and the approval of CBD as a treatment, Mark Devlin, Chief Executive of Young Epilepsy, said: Living with epilepsy can have a significant impact on the lives of children, young people and their families.

Source link

Related posts

Global POC Molecular Diagnostics Market 2019-2023 | Rising Focus on Next-generation Products Drives Growth | Technavio


Long-term use of inexpensive weight-loss drug may be safe and effective


STAT Plus: Amgen’s KRAS-blocking drug shows minimal effect in colon cancer patients


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy